Roman Murashko

Dr. Roman Murashko

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2021 in Kuban Scientific Medical Bulletin
Verified
Journal Article
Open access
PDF file
RMRoman Murashko
Roman Murashko
SAS. N. Alekseenko
S. N. Alekseenko
AKA. A. Koshkarov
A. A. Koshkarov
LTL. G. Teslenko
L. G. Teslenko
MKM. A. Korogod
M. A. Korogod
IRI. T. Rubtsova
I. T. Rubtsova
Особенности маршрутизации пациентов и применения процессного подхода в онкологической службе на региональном уровне

30 January 2024 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
OSOlga V. Shelemekh
Olga V. Shelemekh
VPViktor L. Popkov
Viktor L. Popkov
AZAndrey V. Zadorozhniy
Andrey V. Zadorozhniy
INIrina B. Nektarevskaya
Irina B. Nektarevskaya
NKNikolay E. Korovaykin
Nikolay E. Korovaykin
Introduction: Although nonsteroidal anti-inflammatory drugs (NSAIDs) have a clear therapeutic benefit, they can also have serious side effects. The most serious of these is the ulcerogenic effect, which can result in a decline in the quality of life or even death. This calls for the search for and creation of novel compounds with potent anti-inflammatory properties that do not have adverse effects on the digestive system. The aim of the study was to investigate the anti-inflammatory, analgesic, ulcerogenic and anti-ulcerogenic activities of N-isopropenylimidazole zinc complex derivative. Materials and Methods: Experiments in rats and mice were used to determine the median lethal dose LD50 for N-isopropenylimidazole zinc complex derivative (laboratory name Pilim-1). Experimental models of acute exudative inflammation and chronic proliferative inflammation were used. In the first case, the inflammation was induced by sub-plantar injection of carrageenan and a complete Freund’s adjuvant into the hind paw of rats. In the second case, the inflammation was induced by the implantation of a sterile cotton pellet (“cotton pellet–induced granuloma”) under the skin of rats. Acute and tonic pain, visceral, and somatic deep pain were simulated using the formalin test in rats and the acetic acid-induced writhing test in mice, respectively. The ulcerogenic and anti-ulcerogenic effects of Pilim-1 were studied in rat experiments. Pilim-1 and the reference drugs diclofenac, indomethacin and famotidine were administered intragastrically. Results and Discussion: Pilim-1 showed marked anti-inflammatory and analgesic effects, demonstrated less toxicity than diclofenac and indomethacin, while its activity is comparable to diclofenac and superior to indomethacin. Its therapeutic index is higher than that of indomethacin and diclofenac and, in contrast, it essentially has no ulcerogenic effect and exhibits stronger anti-ulcerogenic activity than famotidine. It appears that the anti-inflammatory, analgesic, and gastroprotective properties of Pilim-1 are largely due to its antioxidant and antihypoxic properties, its inhibitory effects on cyclooxygenase and 5-lipoxygenase, and the presence of imidazole and zinc in its structure, both of which have a wide range of biological activity. Conclusion: Pilim-1 can be recommended for further preclinical studies due to its relatively low (practically absent) ulcerative activity, strong anti-inflammatory, analgesic, and anti-ulcerative effects, greater therapeutic index, and less acute toxicity in comparison with diclofenac and indomethacin.

15 April 2016 in Russian Journal of Oncology
Verified
Journal Article
Open access
PDF file
MKM. V Kazantseva
M. V Kazantseva
RMRoman Murashko
Roman Murashko
IUI. B Uvarov
I. B Uvarov
VKV. B Kaushansky
V. B Kaushansky
КВКазанцева М. В
Казанцева М. В
КБКаушанский В. Б
Каушанский В. Б
Aim of the study. a comparative assessment of perioperative parameters and short-term outcomes of robotic and laparoscopic surgery for colorectal cancer (CRC). Material and methods. The results of surgical treatment of 101 patients with colorectal cancer underwent robotic (I group, n = 30) and laparoscopic (II group, n = 71) radical operations were analyzed. Results. Surgery duration in I group ranged from 140 to 420 minutes (on average 260,9 ± 80,1 min.), in II group - 120-465 minutes (on average - 243,3 ± 72,9 min.; P = 0,314). Blood loss in I group averaged on 100 ± 29,4 ml (50,0-150,0 ml) compared to 141,7 ± 76 ml in II group (the difference is statistically significant, P = 0,006). Conversion rate, complications, duration of the postoperative period did not have a statistically significant difference between the groups. The study of circular resection margins after robotic surgeries confirmed the radical intervention (R0-resection) in all cases. Differences in the number of lymph nodes (12-22) between the groups were not observed. Conclusion. Safety and efficacy of robotic colorectal surgery is comparable to laparoscopic surgery. Long-term results require further study.

3 May 2024 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ITIvan Y Torshin
Ivan Y Torshin
AGA. N. Gromov
A. N. Gromov
OGOlga Gromova
Olga Gromova
RMRoman Murashko
Roman Murashko
OSO. V. Shelemekh
O. V. Shelemekh
Background. Nonsteroidal anti-inflammatory drugs (NSAIDs) are characterized by ulcerogenic effects and used for effective and safe pharmacotherapy of inflammation and pain. The zinc-containing drug acyzole is a promising anti-inflammatory drug that potentially does not have this drawback. Objective: to conduct chemoreactomic modeling of the pharmacological effects of acyzole and zinc derivatives of well-known NSAIDs (diclofenac, nimesulide, ketorolac).Material and methods. The analysis of the pharmacological capabilities of NSAIDs was based on a chemoinformatic approach, i.e. comparing the chemical structure of the studied molecules with the structures of millions of other molecules with established molecular pharmacological properties. The analysis procedure was based on the latest machine learning technologies developed in the theory of topological and metric analysis of feature descriptions.Results. It was shown that acyzole might have an anti-inflammatory effect due to its impact on the activity of cytokines and, partly, on the metabolism of prostaglandins and leuktrienes. The central effects of acyzole are comparable to those of zinc-NSAIDs. The analgesic effect of acyzole may be associated with kinin receptors inhibition, and weak antihistamine and antinociceptin effects. Acizol may also exhibit a gastroprotective effect. It was established that acyzole, to a lesser extent than the reference molecules, negatively affected the metabolism of vitamins and microelements.Conclusion. Chemoreactomic profiling of acyzole indicates prospects for its use as an anti-inflammatory drug.

19 February 2025 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ASAlina Sergeeva
Alina Sergeeva
ITIvan Y Torshin
Ivan Y Torshin
AGA. N. Gromov
A. N. Gromov
IRI. A. Reyer
I. A. Reyer
ISI. V. Sholl
I. V. Sholl
Background. Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for effective and safe pharmacotherapy of inflammation and pain. NSAIDs usually reduce the level of gastroprotective prostaglandin E2 due to cyclooxygenase-1 inhibition. The zinc-containing candidate molecule N-allylimidazole-zinc (bis-(N-allylimidazole) zinc diacetate) is a promising anti-inflammatory drug, potentially devoid of gastrotoxicity.Objective: chemoreactome modeling of the pharmacological effects of N-allylimidazole-zinc and zinc derivatives of known NSAIDs (diclofenac, nimesulide, ketorolac) using topological analysis of chemographs of numerical prediction in complex feature systems.Material and methods. In silico modeling of the candidate molecule N-allylimidazole-zinc synthesized at Federal Research Center “Favorsky Irkutsk Institute of Chemistry” (Siberian Branch of Russian Academy of Sciences), was carried out using a conglomerate of chemoinformatic molecule analysis methods of Yu.I. Zhuravlev scientific school. These methods include the theory of chemograph analysis, methods for predicting numerical target variables, combinatorial theory of solvability/regularity, topological data analysis. Chemoreactome, pharmacoinformation and chemoneurocytological methods of analyzing the molecules properties are based on chemoreactome methodology, the latest direction in the application of machine learning systems in the field of postgenomic pharmacology. The pharmacological capabilities of molecules within chemoreactome methodology are assessed by comparing the chemical structure of racetam molecules with the structures of molecules for which the molecular pharmacological properties have been studied using artificial intelligence learning algorithms based on big data information presented in PubChem, HMDB, STRING, PharmGKB databases. Based on the entire complex of differences between molecules in interactions with receptor proteins, the “anti-obesity” score was calculated for each as the serial number of this molecule when sorting in descending order the values of the corresponding chemoreactome constants.Results. It was shown that N-allylimidazole-zinc may have anti-inflammatory effect due to the influence on cytokine activity and, in part, on prostaglandin and leuktriene metabolism. Its central effects are comparable to the effects of zinc-NSAIDs. The analgesic potential of N-allylimidazole-zinc may be associated with the inhibition of kinin receptors, weak antihistaminic and antinociceptive properties. The molecule may exhibit a protective effect on epithelial gastric mucosa and does not impair the properties of the stomach mucosal protective layer. It has been shown that N-allylimidazole-zinc, compared to other compounds included in the analysis, has the least negative effect on the metabolism of various vitamins and microelements.Conclusion. Chemoreactome profiling of N-allylimidazole-zinc indicates the prospects for its use as an anti-inflammatory drug.

5 November 2024 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ITIvan Y Torshin
Ivan Y Torshin
AGA. N. Gromov
A. N. Gromov
OGOlga Gromova
Olga Gromova
KSKonstantin Suzdalev
Konstantin Suzdalev
EME.M. I. Muhammad
E.M. I. Muhammad
Background. To plan effective and safe pharmacotherapy for inflammation and pain, it is important to evaluate the mechanisms and spectrum of action of nonsteroidal anti-inflammatory drugs (NSAIDs), including their effects on human proteome.Objective: to identify and evaluate the most significant specific differences of candidate molecule RRS-1 (N-{(Z)-2-(1-methyl-1H-indol-3-yl)1-[(propylamino)carbonyl]vinyl}benzamide) from other NSAIDs through differential chemoreactome analysis.Material and methods. Chemoproteomic modeling of pharmacological effects of RRS-1 molecule and a number of well-known NSAIDs (diclofenac, nimesulide, ketorolac) on human proteome was carried out on the basis of numerical prediction algorithms over the space of heterogeneous feature descriptions, developed in the topological approach to recognition by Yu.I. Zhuravlev and K.V. Rudakov scientific school.Results. Significant differences in the effects of the studied molecules were found for 1232 proteins of human proteome. The features of assessing interactions of the studied molecules with 47 target proteins, which most distinguished the effects of RRS-1 molecule from all others were identified. RRS-1 could activate adenosine and dopamine receptors, cannabinoid receptor 2 and GABAA receptor to a greater extent than other molecules. Activation of these receptors corresponded to anti-inflammatory, anti-nociceptive and neuroprotective effects. RRS-1 could preferably inhibit a number of pro-inflammatory proteins, receptor bradykinin 1, metabotropic glutamate receptor 5, matrix metalloproteinases 8, 9, 12, and blood coagulation factor X. Additionally, RRS-1 molecule showed preferable inhibition of a number of kinases targeted in antitumor and anti-inflammatory therapy. RRS-1, less than other studied molecules, interacted with the receptors of vitamin D3, thyroid hormone, acetylcholine, cannabinoids and opioids, orexin, and various metabolic enzymes, which is important in assessment of the safety of using drugs based on this molecule. RRS-1 characteristically exhibited a moderate profile of antivitamin action: the total score of vitamin and mineral loss (7.4±3.7) was significantly less in comparison to diclofenac (11.7±4.5) and was actually on the same level as nimesulide (6.9±3.7) and ketorolac (6.7±3.6).Conclusion. Chemoreactomic and chemoproteomic profiling of RRS-1 candidate molecule provided pre-experimental assessments of its efficacy and safety through modeling interactions with the human proteome.